Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines
More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Hist...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Yu. A. Kucheryaviy [verfasserIn] E. A. Mayevskaya [verfasserIn] M. L. Akhtaeva [verfasserIn] E. A. Krasnyakova [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Медицинский совет - Remedium Group LLC, 2019, (2013), 3-2, Seite 46-51 |
|---|---|
| Übergeordnetes Werk: |
year:2013 ; number:3-2 ; pages:46-51 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.21518/2079-701X-2013-3-2-46-51 |
|---|
| Katalog-ID: |
DOAJ084375167 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ084375167 | ||
| 003 | DE-627 | ||
| 005 | 20230505014358.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230311s2013 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.21518/2079-701X-2013-3-2-46-51 |2 doi | |
| 035 | |a (DE-627)DOAJ084375167 | ||
| 035 | |a (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a Yu. A. Kucheryaviy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. | ||
| 650 | 4 | |a поражения печени | |
| 650 | 4 | |a неалкогольный стеатогепатит | |
| 650 | 4 | |a эндотоксемия | |
| 650 | 4 | |a лактулоза | |
| 650 | 4 | |a liver lesions | |
| 650 | 4 | |a nonalcoholic steatohepatitis | |
| 650 | 4 | |a endotoxemia | |
| 650 | 4 | |a lactulose | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a E. A. Mayevskaya |e verfasserin |4 aut | |
| 700 | 0 | |a M. L. Akhtaeva |e verfasserin |4 aut | |
| 700 | 0 | |a E. A. Krasnyakova |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Медицинский совет |d Remedium Group LLC, 2019 |g (2013), 3-2, Seite 46-51 |w (DE-627)1760607460 |x 26585790 |7 nnns |
| 773 | 1 | 8 | |g year:2013 |g number:3-2 |g pages:46-51 |
| 856 | 4 | 0 | |u https://doi.org/10.21518/2079-701X-2013-3-2-46-51 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef |z kostenfrei |
| 856 | 4 | 0 | |u https://www.med-sovet.pro/jour/article/view/963 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2079-701X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5790 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2013 |e 3-2 |h 46-51 | ||
| author_variant |
y a k yak e a m eam m l a mla e a k eak |
|---|---|
| matchkey_str |
article:26585790:2013----::oachlctaoeaiiadnetnlirfoahqetooptn |
| hierarchy_sort_str |
2013 |
| publishDate |
2013 |
| allfields |
10.21518/2079-701X-2013-3-2-46-51 doi (DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef DE-627 ger DE-627 rakwb rus Yu. A. Kucheryaviy verfasserin aut Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R E. A. Mayevskaya verfasserin aut M. L. Akhtaeva verfasserin aut E. A. Krasnyakova verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2013), 3-2, Seite 46-51 (DE-627)1760607460 26585790 nnns year:2013 number:3-2 pages:46-51 https://doi.org/10.21518/2079-701X-2013-3-2-46-51 kostenfrei https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef kostenfrei https://www.med-sovet.pro/jour/article/view/963 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3-2 46-51 |
| spelling |
10.21518/2079-701X-2013-3-2-46-51 doi (DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef DE-627 ger DE-627 rakwb rus Yu. A. Kucheryaviy verfasserin aut Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R E. A. Mayevskaya verfasserin aut M. L. Akhtaeva verfasserin aut E. A. Krasnyakova verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2013), 3-2, Seite 46-51 (DE-627)1760607460 26585790 nnns year:2013 number:3-2 pages:46-51 https://doi.org/10.21518/2079-701X-2013-3-2-46-51 kostenfrei https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef kostenfrei https://www.med-sovet.pro/jour/article/view/963 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3-2 46-51 |
| allfields_unstemmed |
10.21518/2079-701X-2013-3-2-46-51 doi (DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef DE-627 ger DE-627 rakwb rus Yu. A. Kucheryaviy verfasserin aut Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R E. A. Mayevskaya verfasserin aut M. L. Akhtaeva verfasserin aut E. A. Krasnyakova verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2013), 3-2, Seite 46-51 (DE-627)1760607460 26585790 nnns year:2013 number:3-2 pages:46-51 https://doi.org/10.21518/2079-701X-2013-3-2-46-51 kostenfrei https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef kostenfrei https://www.med-sovet.pro/jour/article/view/963 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3-2 46-51 |
| allfieldsGer |
10.21518/2079-701X-2013-3-2-46-51 doi (DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef DE-627 ger DE-627 rakwb rus Yu. A. Kucheryaviy verfasserin aut Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R E. A. Mayevskaya verfasserin aut M. L. Akhtaeva verfasserin aut E. A. Krasnyakova verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2013), 3-2, Seite 46-51 (DE-627)1760607460 26585790 nnns year:2013 number:3-2 pages:46-51 https://doi.org/10.21518/2079-701X-2013-3-2-46-51 kostenfrei https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef kostenfrei https://www.med-sovet.pro/jour/article/view/963 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3-2 46-51 |
| allfieldsSound |
10.21518/2079-701X-2013-3-2-46-51 doi (DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef DE-627 ger DE-627 rakwb rus Yu. A. Kucheryaviy verfasserin aut Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R E. A. Mayevskaya verfasserin aut M. L. Akhtaeva verfasserin aut E. A. Krasnyakova verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2013), 3-2, Seite 46-51 (DE-627)1760607460 26585790 nnns year:2013 number:3-2 pages:46-51 https://doi.org/10.21518/2079-701X-2013-3-2-46-51 kostenfrei https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef kostenfrei https://www.med-sovet.pro/jour/article/view/963 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3-2 46-51 |
| language |
Russian |
| source |
In Медицинский совет (2013), 3-2, Seite 46-51 year:2013 number:3-2 pages:46-51 |
| sourceStr |
In Медицинский совет (2013), 3-2, Seite 46-51 year:2013 number:3-2 pages:46-51 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Медицинский совет |
| authorswithroles_txt_mv |
Yu. A. Kucheryaviy @@aut@@ E. A. Mayevskaya @@aut@@ M. L. Akhtaeva @@aut@@ E. A. Krasnyakova @@aut@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
1760607460 |
| id |
DOAJ084375167 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084375167</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014358.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2013 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2013-3-2-46-51</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084375167</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yu. A. Kucheryaviy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51].</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">поражения печени</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">неалкогольный стеатогепатит</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">эндотоксемия</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">лактулоза</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">liver lesions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nonalcoholic steatohepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endotoxemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">lactulose</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Mayevskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. L. Akhtaeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Krasnyakova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2013), 3-2, Seite 46-51</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2013</subfield><subfield code="g">number:3-2</subfield><subfield code="g">pages:46-51</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2013-3-2-46-51</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2013</subfield><subfield code="e">3-2</subfield><subfield code="h">46-51</subfield></datafield></record></collection>
|
| author |
Yu. A. Kucheryaviy |
| spellingShingle |
Yu. A. Kucheryaviy misc поражения печени misc неалкогольный стеатогепатит misc эндотоксемия misc лактулоза misc liver lesions misc nonalcoholic steatohepatitis misc endotoxemia misc lactulose misc Medicine misc R Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| authorStr |
Yu. A. Kucheryaviy |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760607460 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
26585790 |
| topic_title |
Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines поражения печени неалкогольный стеатогепатит эндотоксемия лактулоза liver lesions nonalcoholic steatohepatitis endotoxemia lactulose |
| topic |
misc поражения печени misc неалкогольный стеатогепатит misc эндотоксемия misc лактулоза misc liver lesions misc nonalcoholic steatohepatitis misc endotoxemia misc lactulose misc Medicine misc R |
| topic_unstemmed |
misc поражения печени misc неалкогольный стеатогепатит misc эндотоксемия misc лактулоза misc liver lesions misc nonalcoholic steatohepatitis misc endotoxemia misc lactulose misc Medicine misc R |
| topic_browse |
misc поражения печени misc неалкогольный стеатогепатит misc эндотоксемия misc лактулоза misc liver lesions misc nonalcoholic steatohepatitis misc endotoxemia misc lactulose misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Медицинский совет |
| hierarchy_parent_id |
1760607460 |
| hierarchy_top_title |
Медицинский совет |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760607460 |
| title |
Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| ctrlnum |
(DE-627)DOAJ084375167 (DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef |
| title_full |
Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| author_sort |
Yu. A. Kucheryaviy |
| journal |
Медицинский совет |
| journalStr |
Медицинский совет |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
txt |
| container_start_page |
46 |
| author_browse |
Yu. A. Kucheryaviy E. A. Mayevskaya M. L. Akhtaeva E. A. Krasnyakova |
| format_se |
Elektronische Aufsätze |
| author-letter |
Yu. A. Kucheryaviy |
| doi_str_mv |
10.21518/2079-701X-2013-3-2-46-51 |
| author2-role |
verfasserin |
| title_sort |
nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| title_auth |
Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| abstract |
More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. |
| abstractGer |
More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. |
| abstract_unstemmed |
More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51]. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
3-2 |
| title_short |
Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines |
| url |
https://doi.org/10.21518/2079-701X-2013-3-2-46-51 https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef https://www.med-sovet.pro/jour/article/view/963 https://doaj.org/toc/2079-701X https://doaj.org/toc/2658-5790 |
| remote_bool |
true |
| author2 |
E. A. Mayevskaya M. L. Akhtaeva E. A. Krasnyakova |
| author2Str |
E. A. Mayevskaya M. L. Akhtaeva E. A. Krasnyakova |
| ppnlink |
1760607460 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.21518/2079-701X-2013-3-2-46-51 |
| up_date |
2024-07-03T22:39:44.387Z |
| _version_ |
1803599357557080064 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084375167</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014358.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2013 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2013-3-2-46-51</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084375167</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2c6a656aa7774c20861f503febaa61ef</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yu. A. Kucheryaviy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nonalcoholic steatohepatitis and intestinal microflora: the question of potential of prebiotic medicines</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More than 30 years ago, Jurgen Ludwig et al. from Mayo Clinic (USA, Minnesota) for the first time at biopsy described typical signs of parenchyma lesions in alcoholic liver disease in patients who did not consume hepatotoxic doses of alcohol but were suffering from obesity and type II diabetes. Histological examination of biopsy specimens revealed not only fatty liver, but also hepatocyte ballooning with concurrent lobular and portal leukocyte infiltration [32]. The resulting morphological picture did not fit into the earlier defined criteria for fatty liver disease; the term "non-alcoholic steatohepatitis" (NASH) was first proposed by the researchers, which subsequently secured its place in the vocabulary of both practitioners and scholars. Further studies in different regions of the world led to separating NASH as a nosological entity in the structure of liver diseases characterized by inflammation and cytolytic syndrome [21, 30, 48, 51].</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">поражения печени</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">неалкогольный стеатогепатит</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">эндотоксемия</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">лактулоза</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">liver lesions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nonalcoholic steatohepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endotoxemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">lactulose</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Mayevskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. L. Akhtaeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Krasnyakova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2013), 3-2, Seite 46-51</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2013</subfield><subfield code="g">number:3-2</subfield><subfield code="g">pages:46-51</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2013-3-2-46-51</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2c6a656aa7774c20861f503febaa61ef</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/963</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2013</subfield><subfield code="e">3-2</subfield><subfield code="h">46-51</subfield></datafield></record></collection>
|
| score |
7.402916 |